SOFINNOVA CAPITAL VI FCPR 4
4 · HOOKIPA Pharma Inc. · Filed Sep 17, 2020
Insider Transaction Report
Form 4
SOFINNOVA CAPITAL VI FCPR
10% Owner
Transactions
- Sale
Common Stock
2020-09-15$12.45/sh−32,336$402,564→ 3,915,755 total - Sale
Common Stock
2020-09-15$13.16/sh−9,261$121,913→ 3,906,494 total
Footnotes (4)
- [F1]Shares sold pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.01 to $13.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Sofinnova Partners SAS is the managing company of Sofinnova Capital VI FCPR and disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, if any.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.